nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—Fluorouracil—urinary bladder cancer	0.0889	0.208	CbGbCtD
Cephalexin—CYP3A4—Thiotepa—urinary bladder cancer	0.0858	0.2	CbGbCtD
Cephalexin—SLC22A8—Methotrexate—urinary bladder cancer	0.0827	0.193	CbGbCtD
Cephalexin—SLC22A6—Methotrexate—urinary bladder cancer	0.0576	0.134	CbGbCtD
Cephalexin—ALB—Methotrexate—urinary bladder cancer	0.049	0.115	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—urinary bladder cancer	0.025	0.0583	CbGbCtD
Cephalexin—CYP3A4—Etoposide—urinary bladder cancer	0.0233	0.0543	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0159	0.0371	CbGbCtD
Cephalexin—SLC22A8—urine—urinary bladder cancer	0.0143	0.113	CbGeAlD
Cephalexin—CYP3A4—urine—urinary bladder cancer	0.00711	0.0558	CbGeAlD
Cephalexin—CYP2D6—urine—urinary bladder cancer	0.00699	0.0549	CbGeAlD
Cephalexin—SLC47A1—prostate gland—urinary bladder cancer	0.00671	0.0527	CbGeAlD
Cephalexin—SLC47A1—seminal vesicle—urinary bladder cancer	0.00567	0.0446	CbGeAlD
Cephalexin—SLC15A1—epithelium—urinary bladder cancer	0.00526	0.0413	CbGeAlD
Cephalexin—SLC22A8—prostate gland—urinary bladder cancer	0.00515	0.0404	CbGeAlD
Cephalexin—SLC15A1—renal system—urinary bladder cancer	0.00488	0.0383	CbGeAlD
Cephalexin—SLC47A1—renal system—urinary bladder cancer	0.00457	0.0359	CbGeAlD
Cephalexin—SLC47A1—urethra—urinary bladder cancer	0.00449	0.0353	CbGeAlD
Cephalexin—SLC15A2—prostate gland—urinary bladder cancer	0.00447	0.0351	CbGeAlD
Cephalexin—SLC22A5—prostate gland—urinary bladder cancer	0.00389	0.0305	CbGeAlD
Cephalexin—SLC15A2—seminal vesicle—urinary bladder cancer	0.00378	0.0297	CbGeAlD
Cephalexin—SLC47A1—female reproductive system—urinary bladder cancer	0.00366	0.0288	CbGeAlD
Cephalexin—SLC15A1—vagina—urinary bladder cancer	0.00353	0.0277	CbGeAlD
Cephalexin—SLC22A8—renal system—urinary bladder cancer	0.00351	0.0275	CbGeAlD
Cephalexin—SLC47A1—vagina—urinary bladder cancer	0.00331	0.026	CbGeAlD
Cephalexin—SLC22A5—seminal vesicle—urinary bladder cancer	0.00329	0.0258	CbGeAlD
Cephalexin—SLC15A2—renal system—urinary bladder cancer	0.00305	0.0239	CbGeAlD
Cephalexin—SLC15A2—urethra—urinary bladder cancer	0.00299	0.0235	CbGeAlD
Cephalexin—SLC22A5—renal system—urinary bladder cancer	0.00265	0.0208	CbGeAlD
Cephalexin—SLC22A5—urethra—urinary bladder cancer	0.0026	0.0205	CbGeAlD
Cephalexin—SLC15A2—female reproductive system—urinary bladder cancer	0.00244	0.0192	CbGeAlD
Cephalexin—SLC15A2—vagina—urinary bladder cancer	0.00221	0.0173	CbGeAlD
Cephalexin—SLC47A1—lymph node—urinary bladder cancer	0.00214	0.0168	CbGeAlD
Cephalexin—SLC22A5—female reproductive system—urinary bladder cancer	0.00212	0.0167	CbGeAlD
Cephalexin—SLC22A5—vagina—urinary bladder cancer	0.00192	0.0151	CbGeAlD
Cephalexin—CYP3A4—renal system—urinary bladder cancer	0.00174	0.0137	CbGeAlD
Cephalexin—ALB—lymph node—urinary bladder cancer	0.00171	0.0134	CbGeAlD
Cephalexin—CYP2D6—renal system—urinary bladder cancer	0.00171	0.0134	CbGeAlD
Cephalexin—CYP2D6—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00155	0.0628	CbGpPWpGaD
Cephalexin—SLC15A2—lymph node—urinary bladder cancer	0.00143	0.0112	CbGeAlD
Cephalexin—Cefdinir—MPO—urinary bladder cancer	0.00142	0.502	CrCbGaD
Cephalexin—Cefaclor—MPO—urinary bladder cancer	0.00141	0.498	CrCbGaD
Cephalexin—CYP3A4—female reproductive system—urinary bladder cancer	0.00139	0.0109	CbGeAlD
Cephalexin—CYP2D6—female reproductive system—urinary bladder cancer	0.00137	0.0108	CbGeAlD
Cephalexin—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00136	0.0553	CbGpPWpGaD
Cephalexin—SLC22A5—lymph node—urinary bladder cancer	0.00124	0.00976	CbGeAlD
Cephalexin—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00101	0.0411	CbGpPWpGaD
Cephalexin—CYP2D6—Miscellaneous substrates—CYP4B1—urinary bladder cancer	0.00101	0.0409	CbGpPWpGaD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.00087	0.00209	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00087	0.00209	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000865	0.00208	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000861	0.00207	CcSEcCtD
Cephalexin—Fatigue—Thiotepa—urinary bladder cancer	0.00086	0.00206	CcSEcCtD
Cephalexin—Leukopenia—Cisplatin—urinary bladder cancer	0.000858	0.00206	CcSEcCtD
Cephalexin—CYP2D6—Fatty acids—CYP4B1—urinary bladder cancer	0.000844	0.0342	CbGpPWpGaD
Cephalexin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000839	0.00201	CcSEcCtD
Cephalexin—Confusional state—Fluorouracil—urinary bladder cancer	0.000832	0.002	CcSEcCtD
Cephalexin—Convulsion—Cisplatin—urinary bladder cancer	0.000831	0.00199	CcSEcCtD
Cephalexin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000825	0.00198	CcSEcCtD
Cephalexin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000823	0.00197	CcSEcCtD
Cephalexin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000822	0.00197	CcSEcCtD
Cephalexin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000822	0.00197	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—urinary bladder cancer	0.000817	0.00196	CcSEcCtD
Cephalexin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000816	0.00196	CcSEcCtD
Cephalexin—Skin disorder—Gemcitabine—urinary bladder cancer	0.000815	0.00196	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00081	0.00194	CcSEcCtD
Cephalexin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000809	0.00194	CcSEcCtD
Cephalexin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000808	0.00194	CcSEcCtD
Cephalexin—Urticaria—Thiotepa—urinary bladder cancer	0.000793	0.0019	CcSEcCtD
Cephalexin—Breast disorder—Methotrexate—urinary bladder cancer	0.000789	0.00189	CcSEcCtD
Cephalexin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000789	0.00189	CcSEcCtD
Cephalexin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000789	0.00189	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000787	0.00189	CcSEcCtD
Cephalexin—Leukopenia—Etoposide—urinary bladder cancer	0.000786	0.00189	CcSEcCtD
Cephalexin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000782	0.00188	CcSEcCtD
Cephalexin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000767	0.00184	CcSEcCtD
Cephalexin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000766	0.00184	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000766	0.00184	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000765	0.00183	CcSEcCtD
Cephalexin—Convulsion—Etoposide—urinary bladder cancer	0.000761	0.00182	CcSEcCtD
Cephalexin—Skin disorder—Cisplatin—urinary bladder cancer	0.00076	0.00182	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000756	0.00181	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000752	0.0018	CcSEcCtD
Cephalexin—Eosinophilia—Methotrexate—urinary bladder cancer	0.000747	0.00179	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000743	0.00178	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—urinary bladder cancer	0.000739	0.00177	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000736	0.00177	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000736	0.00177	CcSEcCtD
Cephalexin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000735	0.00176	CcSEcCtD
Cephalexin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000726	0.00174	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000725	0.00174	CcSEcCtD
Cephalexin—Fatigue—Gemcitabine—urinary bladder cancer	0.000724	0.00174	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—urinary bladder cancer	0.000723	0.00173	CcSEcCtD
Cephalexin—Confusional state—Etoposide—urinary bladder cancer	0.000723	0.00173	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000721	0.00173	CcSEcCtD
Cephalexin—Pancytopenia—Methotrexate—urinary bladder cancer	0.000717	0.00172	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000717	0.00172	CcSEcCtD
Cephalexin—CYP2D6—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000716	0.029	CbGpPWpGaD
Cephalexin—Asthenia—Thiotepa—urinary bladder cancer	0.000716	0.00172	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000713	0.00171	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000712	0.00171	CcSEcCtD
Cephalexin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000711	0.0288	CbGpPWpGaD
Cephalexin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000709	0.0017	CcSEcCtD
Cephalexin—Neutropenia—Methotrexate—urinary bladder cancer	0.000706	0.00169	CcSEcCtD
Cephalexin—Pruritus—Thiotepa—urinary bladder cancer	0.000706	0.00169	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000702	0.00168	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—urinary bladder cancer	0.0007	0.00168	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—urinary bladder cancer	0.000696	0.00167	CcSEcCtD
Cephalexin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000692	0.00166	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—urinary bladder cancer	0.000683	0.00164	CcSEcCtD
Cephalexin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000683	0.00164	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000681	0.00163	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000681	0.00163	CcSEcCtD
Cephalexin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00068	0.00163	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000675	0.00162	CcSEcCtD
Cephalexin—Infestation NOS—Methotrexate—urinary bladder cancer	0.000673	0.00161	CcSEcCtD
Cephalexin—Infestation—Methotrexate—urinary bladder cancer	0.000673	0.00161	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—urinary bladder cancer	0.000671	0.00161	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—urinary bladder cancer	0.000669	0.00161	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000667	0.0016	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000667	0.0016	CcSEcCtD
Cephalexin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000664	0.00159	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—urinary bladder cancer	0.000661	0.00158	CcSEcCtD
Cephalexin—Dizziness—Thiotepa—urinary bladder cancer	0.00066	0.00158	CcSEcCtD
Cephalexin—Urticaria—Fluorouracil—urinary bladder cancer	0.000656	0.00157	CcSEcCtD
Cephalexin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000652	0.00156	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000647	0.00155	CcSEcCtD
Cephalexin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000645	0.00155	CcSEcCtD
Cephalexin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000643	0.026	CbGpPWpGaD
Cephalexin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000637	0.00153	CcSEcCtD
Cephalexin—Vomiting—Thiotepa—urinary bladder cancer	0.000634	0.00152	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—urinary bladder cancer	0.00063	0.00151	CcSEcCtD
Cephalexin—Infestation—Epirubicin—urinary bladder cancer	0.00063	0.00151	CcSEcCtD
Cephalexin—Rash—Thiotepa—urinary bladder cancer	0.000629	0.00151	CcSEcCtD
Cephalexin—Dermatitis—Thiotepa—urinary bladder cancer	0.000629	0.00151	CcSEcCtD
Cephalexin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000628	0.00151	CcSEcCtD
Cephalexin—Headache—Thiotepa—urinary bladder cancer	0.000625	0.0015	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000625	0.0015	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000621	0.00149	CcSEcCtD
Cephalexin—SLC47A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00062	0.0251	CbGpPWpGaD
Cephalexin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000619	0.00148	CcSEcCtD
Cephalexin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000618	0.00148	CcSEcCtD
Cephalexin—Fatigue—Etoposide—urinary bladder cancer	0.000618	0.00148	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000611	0.00147	CcSEcCtD
Cephalexin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000608	0.00146	CcSEcCtD
Cephalexin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000607	0.00146	CcSEcCtD
Cephalexin—Hepatitis—Methotrexate—urinary bladder cancer	0.000604	0.00145	CcSEcCtD
Cephalexin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000604	0.00145	CcSEcCtD
Cephalexin—Asthenia—Gemcitabine—urinary bladder cancer	0.000602	0.00144	CcSEcCtD
Cephalexin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000597	0.00143	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000596	0.00143	CcSEcCtD
Cephalexin—Pruritus—Gemcitabine—urinary bladder cancer	0.000594	0.00142	CcSEcCtD
Cephalexin—Nausea—Thiotepa—urinary bladder cancer	0.000593	0.00142	CcSEcCtD
Cephalexin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000592	0.00142	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000591	0.00142	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000588	0.00141	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000586	0.00141	CcSEcCtD
Cephalexin—Pruritus—Fluorouracil—urinary bladder cancer	0.000584	0.0014	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000583	0.0014	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—urinary bladder cancer	0.000583	0.0014	CcSEcCtD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000581	0.0235	CbGpPWpGaD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000578	0.00139	CcSEcCtD
Cephalexin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000576	0.00138	CcSEcCtD
Cephalexin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000574	0.00138	CcSEcCtD
Cephalexin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000571	0.00137	CcSEcCtD
Cephalexin—Urticaria—Etoposide—urinary bladder cancer	0.000569	0.00137	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000568	0.00136	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—urinary bladder cancer	0.000567	0.00136	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—urinary bladder cancer	0.000567	0.00136	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000566	0.00136	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—urinary bladder cancer	0.000566	0.00136	CcSEcCtD
Cephalexin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000565	0.00135	CcSEcCtD
Cephalexin—Asthenia—Cisplatin—urinary bladder cancer	0.000561	0.00135	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000558	0.00134	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000556	0.00133	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000554	0.00133	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000551	0.00132	CcSEcCtD
Cephalexin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000546	0.00131	CcSEcCtD
Cephalexin—Dizziness—Fluorouracil—urinary bladder cancer	0.000546	0.00131	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000544	0.0013	CcSEcCtD
Cephalexin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000536	0.0217	CbGpPWpGaD
Cephalexin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000535	0.00128	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000535	0.00128	CcSEcCtD
Cephalexin—Vomiting—Gemcitabine—urinary bladder cancer	0.000534	0.00128	CcSEcCtD
Cephalexin—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00053	0.0215	CbGpPWpGaD
Cephalexin—Mental disorder—Methotrexate—urinary bladder cancer	0.000529	0.00127	CcSEcCtD
Cephalexin—Rash—Gemcitabine—urinary bladder cancer	0.000529	0.00127	CcSEcCtD
Cephalexin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000529	0.00127	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000528	0.00127	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000526	0.00126	CcSEcCtD
Cephalexin—Headache—Gemcitabine—urinary bladder cancer	0.000526	0.00126	CcSEcCtD
Cephalexin—Vomiting—Fluorouracil—urinary bladder cancer	0.000525	0.00126	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000523	0.00125	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000523	0.00125	CcSEcCtD
Cephalexin—Rash—Fluorouracil—urinary bladder cancer	0.00052	0.00125	CcSEcCtD
Cephalexin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00052	0.00125	CcSEcCtD
Cephalexin—Headache—Fluorouracil—urinary bladder cancer	0.000517	0.00124	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000517	0.00124	CcSEcCtD
Cephalexin—Asthenia—Etoposide—urinary bladder cancer	0.000514	0.00123	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000514	0.00123	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000513	0.00123	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000511	0.00122	CcSEcCtD
Cephalexin—Pruritus—Etoposide—urinary bladder cancer	0.000507	0.00122	CcSEcCtD
Cephalexin—Nausea—Gemcitabine—urinary bladder cancer	0.000499	0.0012	CcSEcCtD
Cephalexin—Vomiting—Cisplatin—urinary bladder cancer	0.000497	0.00119	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—urinary bladder cancer	0.000495	0.00119	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000495	0.00119	CcSEcCtD
Cephalexin—Rash—Cisplatin—urinary bladder cancer	0.000493	0.00118	CcSEcCtD
Cephalexin—Dermatitis—Cisplatin—urinary bladder cancer	0.000493	0.00118	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—urinary bladder cancer	0.00049	0.00118	CcSEcCtD
Cephalexin—Nausea—Fluorouracil—urinary bladder cancer	0.00049	0.00118	CcSEcCtD
Cephalexin—Dizziness—Etoposide—urinary bladder cancer	0.000474	0.00114	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000473	0.00113	CcSEcCtD
Cephalexin—Leukopenia—Methotrexate—urinary bladder cancer	0.000471	0.00113	CcSEcCtD
Cephalexin—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000468	0.019	CbGpPWpGaD
Cephalexin—Nausea—Cisplatin—urinary bladder cancer	0.000465	0.00111	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000458	0.0011	CcSEcCtD
Cephalexin—Convulsion—Methotrexate—urinary bladder cancer	0.000456	0.00109	CcSEcCtD
Cephalexin—Vomiting—Etoposide—urinary bladder cancer	0.000456	0.00109	CcSEcCtD
Cephalexin—Agitation—Epirubicin—urinary bladder cancer	0.000452	0.00108	CcSEcCtD
Cephalexin—Rash—Etoposide—urinary bladder cancer	0.000452	0.00108	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—urinary bladder cancer	0.000451	0.00108	CcSEcCtD
Cephalexin—Headache—Etoposide—urinary bladder cancer	0.000449	0.00108	CcSEcCtD
Cephalexin—Arthralgia—Methotrexate—urinary bladder cancer	0.000448	0.00107	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000445	0.00107	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—urinary bladder cancer	0.000441	0.00106	CcSEcCtD
Cephalexin—Confusional state—Methotrexate—urinary bladder cancer	0.000433	0.00104	CcSEcCtD
Cephalexin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000429	0.00103	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—urinary bladder cancer	0.000427	0.00102	CcSEcCtD
Cephalexin—Nausea—Etoposide—urinary bladder cancer	0.000426	0.00102	CcSEcCtD
Cephalexin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000421	0.00101	CcSEcCtD
Cephalexin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00042	0.00101	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—urinary bladder cancer	0.000419	0.00101	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—urinary bladder cancer	0.000419	0.001	CcSEcCtD
Cephalexin—Skin disorder—Methotrexate—urinary bladder cancer	0.000417	0.001	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000416	0.000998	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000408	0.000978	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—urinary bladder cancer	0.000405	0.000972	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000402	0.000964	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—urinary bladder cancer	0.000395	0.000946	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000394	0.000945	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000393	0.000943	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000391	0.000938	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—urinary bladder cancer	0.00039	0.000936	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000388	0.00093	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000385	0.000924	CcSEcCtD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00038	0.0154	CbGpPWpGaD
Cephalexin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000378	0.000906	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—urinary bladder cancer	0.000375	0.000899	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000372	0.000892	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000371	0.000889	CcSEcCtD
Cephalexin—Fatigue—Methotrexate—urinary bladder cancer	0.00037	0.000888	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000366	0.000878	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000365	0.000874	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000364	0.000873	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000361	0.000866	CcSEcCtD
Cephalexin—SLC15A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000354	0.0143	CbGpPWpGaD
Cephalexin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000354	0.000848	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000354	0.000848	CcSEcCtD
Cephalexin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000351	0.000842	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000347	0.000832	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—urinary bladder cancer	0.000346	0.000831	CcSEcCtD
Cephalexin—Urticaria—Methotrexate—urinary bladder cancer	0.000341	0.000818	CcSEcCtD
Cephalexin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000339	0.000814	CcSEcCtD
Cephalexin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000339	0.000814	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000339	0.000812	CcSEcCtD
Cephalexin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000334	0.0135	CbGpPWpGaD
Cephalexin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000331	0.000794	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000329	0.000788	CcSEcCtD
Cephalexin—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000328	0.0133	CbGpPWpGaD
Cephalexin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000327	0.000785	CcSEcCtD
Cephalexin—SLC22A5—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000323	0.0131	CbGpPWpGaD
Cephalexin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000321	0.00077	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—urinary bladder cancer	0.000321	0.000769	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—urinary bladder cancer	0.000319	0.000765	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000318	0.000762	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000318	0.000762	CcSEcCtD
Cephalexin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000316	0.000759	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000315	0.0128	CbGpPWpGaD
Cephalexin—Asthenia—Methotrexate—urinary bladder cancer	0.000308	0.000739	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000306	0.000735	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000304	0.000729	CcSEcCtD
Cephalexin—Pruritus—Methotrexate—urinary bladder cancer	0.000304	0.000728	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000296	0.00071	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—urinary bladder cancer	0.000295	0.000708	CcSEcCtD
Cephalexin—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000295	0.012	CbGpPWpGaD
Cephalexin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000294	0.000705	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000294	0.000705	CcSEcCtD
Cephalexin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000294	0.000704	CcSEcCtD
Cephalexin—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000292	0.0118	CbGpPWpGaD
Cephalexin—Asthenia—Epirubicin—urinary bladder cancer	0.000288	0.000691	CcSEcCtD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000287	0.0116	CbGpPWpGaD
Cephalexin—Pruritus—Epirubicin—urinary bladder cancer	0.000284	0.000682	CcSEcCtD
Cephalexin—Dizziness—Methotrexate—urinary bladder cancer	0.000284	0.000681	CcSEcCtD
Cephalexin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000278	0.0113	CbGpPWpGaD
Cephalexin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000275	0.000659	CcSEcCtD
Cephalexin—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000275	0.0111	CbGpPWpGaD
Cephalexin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000274	0.000657	CcSEcCtD
Cephalexin—Vomiting—Methotrexate—urinary bladder cancer	0.000273	0.000655	CcSEcCtD
Cephalexin—Rash—Methotrexate—urinary bladder cancer	0.000271	0.000649	CcSEcCtD
Cephalexin—Dermatitis—Methotrexate—urinary bladder cancer	0.00027	0.000649	CcSEcCtD
Cephalexin—Headache—Methotrexate—urinary bladder cancer	0.000269	0.000645	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—urinary bladder cancer	0.000267	0.00064	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—urinary bladder cancer	0.000266	0.000637	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—urinary bladder cancer	0.000263	0.000631	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—urinary bladder cancer	0.000255	0.000613	CcSEcCtD
Cephalexin—Nausea—Methotrexate—urinary bladder cancer	0.000255	0.000612	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000254	0.00061	CcSEcCtD
Cephalexin—Rash—Epirubicin—urinary bladder cancer	0.000253	0.000608	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—urinary bladder cancer	0.000253	0.000607	CcSEcCtD
Cephalexin—Headache—Epirubicin—urinary bladder cancer	0.000252	0.000604	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—urinary bladder cancer	0.000246	0.00059	CcSEcCtD
Cephalexin—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000244	0.00988	CbGpPWpGaD
Cephalexin—Nausea—Epirubicin—urinary bladder cancer	0.000239	0.000572	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—urinary bladder cancer	0.000236	0.000567	CcSEcCtD
Cephalexin—Rash—Doxorubicin—urinary bladder cancer	0.000234	0.000562	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000234	0.000562	CcSEcCtD
Cephalexin—Headache—Doxorubicin—urinary bladder cancer	0.000233	0.000559	CcSEcCtD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000228	0.00923	CbGpPWpGaD
Cephalexin—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000226	0.00915	CbGpPWpGaD
Cephalexin—Nausea—Doxorubicin—urinary bladder cancer	0.000221	0.00053	CcSEcCtD
Cephalexin—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000209	0.00847	CbGpPWpGaD
Cephalexin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000204	0.00829	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.000202	0.00818	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000186	0.00752	CbGpPWpGaD
Cephalexin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000182	0.00738	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00018	0.00729	CbGpPWpGaD
Cephalexin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00018	0.00728	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000167	0.00676	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.000164	0.00665	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000164	0.00665	CbGpPWpGaD
Cephalexin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000157	0.00635	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000154	0.00622	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000151	0.00614	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000148	0.00601	CbGpPWpGaD
Cephalexin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000148	0.00598	CbGpPWpGaD
Cephalexin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000147	0.00596	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000146	0.0059	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000146	0.0059	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000144	0.00582	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000133	0.0054	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000131	0.00532	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.00013	0.00528	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00013	0.00527	CbGpPWpGaD
Cephalexin—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000127	0.00513	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000127	0.00513	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000125	0.00508	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000124	0.00502	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000121	0.00489	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00012	0.00486	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000119	0.00481	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000118	0.00479	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000112	0.00452	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000107	0.00435	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000106	0.00429	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000103	0.00418	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.0001	0.00407	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	9.9e-05	0.00401	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.83e-05	0.00399	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—GPX1—urinary bladder cancer	9.83e-05	0.00398	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.67e-05	0.00392	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	9.52e-05	0.00386	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	9.52e-05	0.00386	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	9.39e-05	0.0038	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	9.07e-05	0.00368	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.95e-05	0.00363	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.75e-05	0.00354	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	8.71e-05	0.00353	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	8.59e-05	0.00348	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	8.19e-05	0.00332	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	7.98e-05	0.00323	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	7.87e-05	0.00319	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	7.84e-05	0.00318	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	7.81e-05	0.00317	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	7.73e-05	0.00313	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.3e-05	0.00296	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	7.21e-05	0.00292	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.16e-05	0.0029	CbGpPWpGaD
Cephalexin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	6.75e-05	0.00274	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.64e-05	0.00269	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.53e-05	0.00265	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	6.44e-05	0.00261	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	6.38e-05	0.00258	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	6.19e-05	0.00251	CbGpPWpGaD
Cephalexin—ALB—Platelet degranulation—IGF1—urinary bladder cancer	5.98e-05	0.00243	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.91e-05	0.00239	CbGpPWpGaD
Cephalexin—SLC47A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.87e-05	0.00238	CbGpPWpGaD
Cephalexin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	5.7e-05	0.00231	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	5.58e-05	0.00226	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—IL2—urinary bladder cancer	5.37e-05	0.00217	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	5.22e-05	0.00211	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.14e-05	0.00208	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.93e-05	0.002	CbGpPWpGaD
Cephalexin—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	4.8e-05	0.00195	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.65e-05	0.00189	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	4.6e-05	0.00186	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	4.29e-05	0.00174	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.23e-05	0.00171	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.17e-05	0.00169	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.04e-05	0.00164	CbGpPWpGaD
Cephalexin—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	3.94e-05	0.0016	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TNF—urinary bladder cancer	3.91e-05	0.00158	CbGpPWpGaD
Cephalexin—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.89e-05	0.00157	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.79e-05	0.00154	CbGpPWpGaD
Cephalexin—ALB—Folate Metabolism—TP53—urinary bladder cancer	3.45e-05	0.0014	CbGpPWpGaD
Cephalexin—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.35e-05	0.00136	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTZ1—urinary bladder cancer	3.18e-05	0.00129	CbGpPWpGaD
Cephalexin—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.11e-05	0.00126	CbGpPWpGaD
Cephalexin—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	3.1e-05	0.00126	CbGpPWpGaD
Cephalexin—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.06e-05	0.00124	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTO2—urinary bladder cancer	3.02e-05	0.00122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAT1—urinary bladder cancer	3.02e-05	0.00122	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.97e-05	0.0012	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.8e-05	0.00114	CbGpPWpGaD
Cephalexin—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.76e-05	0.00112	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.76e-05	0.00112	CbGpPWpGaD
Cephalexin—ALB—Metabolism—UGT2B7—urinary bladder cancer	2.76e-05	0.00112	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	2.65e-05	0.00108	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	2.63e-05	0.00106	CbGpPWpGaD
Cephalexin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.58e-05	0.00104	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.56e-05	0.00104	CbGpPWpGaD
Cephalexin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.54e-05	0.00103	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	2.49e-05	0.00101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAT1—urinary bladder cancer	2.49e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP4B1—urinary bladder cancer	2.48e-05	0.00101	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	2.43e-05	0.000986	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IFNA2—urinary bladder cancer	2.37e-05	0.000959	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC19A1—urinary bladder cancer	2.35e-05	0.00095	CbGpPWpGaD
Cephalexin—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.31e-05	0.000935	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PRSS3—urinary bladder cancer	2.29e-05	0.000926	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	2.28e-05	0.000923	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.05e-05	0.000831	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.04e-05	0.000827	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.94e-05	0.000785	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.89e-05	0.000765	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.83e-05	0.000743	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TYMP—urinary bladder cancer	1.83e-05	0.00074	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	1.78e-05	0.000722	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.75e-05	0.000711	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.72e-05	0.000696	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAU—urinary bladder cancer	1.68e-05	0.000681	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAT2—urinary bladder cancer	1.65e-05	0.00067	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.63e-05	0.00066	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.63e-05	0.00066	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.51e-05	0.000611	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.49e-05	0.000603	CbGpPWpGaD
Cephalexin—ALB—Metabolism—RRM2—urinary bladder cancer	1.43e-05	0.000578	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.39e-05	0.000562	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF1—urinary bladder cancer	1.37e-05	0.000555	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.36e-05	0.000553	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.34e-05	0.000543	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HPGDS—urinary bladder cancer	1.32e-05	0.000535	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ENO2—urinary bladder cancer	1.32e-05	0.000535	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.31e-05	0.000532	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTT1—urinary bladder cancer	1.28e-05	0.000519	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.27e-05	0.000513	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.26e-05	0.000511	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—RHOA—urinary bladder cancer	1.25e-05	0.000508	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.23e-05	0.0005	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.2e-05	0.000486	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.18e-05	0.000477	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.09e-05	0.000442	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.09e-05	0.000442	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NQO1—urinary bladder cancer	1.06e-05	0.000431	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.06e-05	0.000429	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—urinary bladder cancer	1.05e-05	0.000426	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.03e-05	0.000419	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.86e-06	0.0004	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—EP300—urinary bladder cancer	9.44e-06	0.000382	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SRC—urinary bladder cancer	9.18e-06	0.000372	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.01e-06	0.000365	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.92e-06	0.000361	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—urinary bladder cancer	8.88e-06	0.00036	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.79e-06	0.000356	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.59e-06	0.000348	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TYMS—urinary bladder cancer	8.26e-06	0.000335	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOR1—urinary bladder cancer	8.16e-06	0.000331	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—urinary bladder cancer	8.16e-06	0.000331	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX1—urinary bladder cancer	7.81e-06	0.000317	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.7e-06	0.000312	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ERCC2—urinary bladder cancer	7.67e-06	0.000311	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KRAS—urinary bladder cancer	7.6e-06	0.000308	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7.33e-06	0.000297	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—urinary bladder cancer	7.21e-06	0.000292	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	7.13e-06	0.000289	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	7.13e-06	0.000289	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.92e-06	0.00028	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.82e-06	0.000276	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—urinary bladder cancer	6.75e-06	0.000274	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.74e-06	0.000273	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.74e-06	0.000273	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—HRAS—urinary bladder cancer	6.46e-06	0.000262	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.45e-06	0.000261	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.33e-06	0.000257	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.95e-06	0.000241	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARG—urinary bladder cancer	5.85e-06	0.000237	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.75e-06	0.000233	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CREBBP—urinary bladder cancer	5.62e-06	0.000228	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.83e-06	0.000196	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.79e-06	0.000194	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.64e-06	0.000188	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS2—urinary bladder cancer	4.6e-06	0.000186	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.46e-06	0.000181	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.41e-06	0.000179	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.41e-06	0.000179	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.22e-06	0.000171	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.14e-06	0.000168	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTEN—urinary bladder cancer	4.01e-06	0.000163	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.89e-06	0.000158	CbGpPWpGaD
Cephalexin—ALB—Metabolism—EP300—urinary bladder cancer	3.83e-06	0.000155	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.8e-06	0.000154	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.31e-06	0.000134	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.16e-06	0.000128	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.16e-06	0.000128	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.03e-06	0.000123	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.48e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.17e-06	8.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.07e-06	8.37e-05	CbGpPWpGaD
